Cargando…

Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center

INTRODUCTION: Spinal cord decompression sickness (scDCS) unfortunately has a high rate of long-term sequelae. The purpose of this study was to determine the best therapeutic management in a hyperbaric center and, in particular, the influence of hyperbaric treatment performed according to tables at 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonnet, Benjamin, Roffi, Romain, Lehot, Henri, Morin, Jean, Druelle, Arnaud, Daubresse, Lucille, Louge, Pierre, de Maistre, Sébastien, Gempp, Emmanuel, Vallee, Nicolas, Blatteau, Jean-Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514493/
https://www.ncbi.nlm.nih.gov/pubmed/37746073
http://dx.doi.org/10.3389/fmed.2023.1172646
_version_ 1785108741075501056
author Simonnet, Benjamin
Roffi, Romain
Lehot, Henri
Morin, Jean
Druelle, Arnaud
Daubresse, Lucille
Louge, Pierre
de Maistre, Sébastien
Gempp, Emmanuel
Vallee, Nicolas
Blatteau, Jean-Eric
author_facet Simonnet, Benjamin
Roffi, Romain
Lehot, Henri
Morin, Jean
Druelle, Arnaud
Daubresse, Lucille
Louge, Pierre
de Maistre, Sébastien
Gempp, Emmanuel
Vallee, Nicolas
Blatteau, Jean-Eric
author_sort Simonnet, Benjamin
collection PubMed
description INTRODUCTION: Spinal cord decompression sickness (scDCS) unfortunately has a high rate of long-term sequelae. The purpose of this study was to determine the best therapeutic management in a hyperbaric center and, in particular, the influence of hyperbaric treatment performed according to tables at 4 atm (Comex 30) or 2.8 atm abs (USNT5 or T6 equivalent). METHODS: This was a retrospective study that included scDCS with objective sensory or motor deficit affecting the limbs and/or sphincter impairment seen at a single hyperbaric center from 2010 to 2020. Information on dive, time to recompression, and in-hospital management (hyperbaric and medical treatments such as lidocaine) were analyzed as predictor variables, as well as initial clinical severity and clinical deterioration in the first 24 h after initial recompression. The primary endpoint was the presence or absence of sequelae at discharge as assessed by the modified Japanese Orthopaedic Association score. RESULTS: 102 divers (52 ± 16 years, 20 female) were included. In multivariate analysis, high initial clinical severity, deterioration in the first 24 h, and recompression tables at 4 atm versus 2.8 atm abs for both initial and additional recompression were associated with incomplete neurological recovery. Analysis of covariance comparing the effect of initial tables at 2.8 versus 4 atm abs as a function of initial clinical severity showed a significantly lower level of sequelae with tables at 2.8 atm. In studying correlations between exposure times to maximum or cumulative O2 dose and the degree of sequelae, the optimal initial treatment appears to be a balance between administration of a high partial pressure of O2 (2.8 atm) and a limited exposure duration that does not result in pulmonary oxygen toxicity. Further analysis suggests that additional tables in the first 24–48 h at 2.8 atm abs with a Heliox mixture may be beneficial, while the use of lidocaine does not appear to be relevant. CONCLUSION: Our study shows that the risk of sequelae is related not only to initial severity but also to clinical deterioration in the first 24 h, suggesting the activation of biological cascades that can be mitigated by well-adapted initial and complementary hyperbaric treatment.
format Online
Article
Text
id pubmed-10514493
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105144932023-09-23 Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center Simonnet, Benjamin Roffi, Romain Lehot, Henri Morin, Jean Druelle, Arnaud Daubresse, Lucille Louge, Pierre de Maistre, Sébastien Gempp, Emmanuel Vallee, Nicolas Blatteau, Jean-Eric Front Med (Lausanne) Medicine INTRODUCTION: Spinal cord decompression sickness (scDCS) unfortunately has a high rate of long-term sequelae. The purpose of this study was to determine the best therapeutic management in a hyperbaric center and, in particular, the influence of hyperbaric treatment performed according to tables at 4 atm (Comex 30) or 2.8 atm abs (USNT5 or T6 equivalent). METHODS: This was a retrospective study that included scDCS with objective sensory or motor deficit affecting the limbs and/or sphincter impairment seen at a single hyperbaric center from 2010 to 2020. Information on dive, time to recompression, and in-hospital management (hyperbaric and medical treatments such as lidocaine) were analyzed as predictor variables, as well as initial clinical severity and clinical deterioration in the first 24 h after initial recompression. The primary endpoint was the presence or absence of sequelae at discharge as assessed by the modified Japanese Orthopaedic Association score. RESULTS: 102 divers (52 ± 16 years, 20 female) were included. In multivariate analysis, high initial clinical severity, deterioration in the first 24 h, and recompression tables at 4 atm versus 2.8 atm abs for both initial and additional recompression were associated with incomplete neurological recovery. Analysis of covariance comparing the effect of initial tables at 2.8 versus 4 atm abs as a function of initial clinical severity showed a significantly lower level of sequelae with tables at 2.8 atm. In studying correlations between exposure times to maximum or cumulative O2 dose and the degree of sequelae, the optimal initial treatment appears to be a balance between administration of a high partial pressure of O2 (2.8 atm) and a limited exposure duration that does not result in pulmonary oxygen toxicity. Further analysis suggests that additional tables in the first 24–48 h at 2.8 atm abs with a Heliox mixture may be beneficial, while the use of lidocaine does not appear to be relevant. CONCLUSION: Our study shows that the risk of sequelae is related not only to initial severity but also to clinical deterioration in the first 24 h, suggesting the activation of biological cascades that can be mitigated by well-adapted initial and complementary hyperbaric treatment. Frontiers Media S.A. 2023-09-08 /pmc/articles/PMC10514493/ /pubmed/37746073 http://dx.doi.org/10.3389/fmed.2023.1172646 Text en Copyright © 2023 Simonnet, Roffi, Lehot, Morin, Druelle, Daubresse, Louge, Maistre, Gempp, Vallee and Blatteau. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Simonnet, Benjamin
Roffi, Romain
Lehot, Henri
Morin, Jean
Druelle, Arnaud
Daubresse, Lucille
Louge, Pierre
de Maistre, Sébastien
Gempp, Emmanuel
Vallee, Nicolas
Blatteau, Jean-Eric
Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title_full Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title_fullStr Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title_full_unstemmed Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title_short Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
title_sort therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514493/
https://www.ncbi.nlm.nih.gov/pubmed/37746073
http://dx.doi.org/10.3389/fmed.2023.1172646
work_keys_str_mv AT simonnetbenjamin therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT roffiromain therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT lehothenri therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT morinjean therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT druellearnaud therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT daubresselucille therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT lougepierre therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT demaistresebastien therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT gemppemmanuel therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT valleenicolas therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter
AT blatteaujeaneric therapeuticmanagementofseverespinalcorddecompressionsicknessinahyperbariccenter